194 related articles for article (PubMed ID: 7577800)
1. Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides.
Wolpert E; Franksson L; Kärre K
Int Immunol; 1995 Jun; 7(6):919-28. PubMed ID: 7577800
[TBL] [Abstract][Full Text] [Related]
2. Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens.
Yin L; Poirier G; Neth O; Hsuan JJ; Totty NF; Stauss HJ
Int Immunol; 1993 Sep; 5(9):1003-9. PubMed ID: 7694638
[TBL] [Abstract][Full Text] [Related]
3. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.
Wolpert EZ; Grufman P; Sandberg JK; Tegnesjö A; Kärre K
J Immunol; 1998 Nov; 161(9):4499-505. PubMed ID: 9794374
[TBL] [Abstract][Full Text] [Related]
4. Immunodominant minor histocompatibility antigen peptides presented by H2Db molecules.
Nevala WK; Wettstein PJ
Transplantation; 1997 Nov; 64(9):1323-30. PubMed ID: 9371675
[TBL] [Abstract][Full Text] [Related]
5. The molecular and functional characterization of a dominant minor H antigen, H60.
Malarkannan S; Shih PP; Eden PA; Horng T; Zuberi AR; Christianson G; Roopenian D; Shastri N
J Immunol; 1998 Oct; 161(7):3501-9. PubMed ID: 9759870
[TBL] [Abstract][Full Text] [Related]
6. Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens.
Grufman P; Sandberg JK; Wolpert EZ; Kärre K
J Leukoc Biol; 1999 Aug; 66(2):268-71. PubMed ID: 10449165
[TBL] [Abstract][Full Text] [Related]
7. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
[TBL] [Abstract][Full Text] [Related]
8. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
9. The preferential cytolytic T lymphocyte response to immunodominant minor histocompatibility antigen peptides.
Nevala WK; Wettstein PJ
Transplantation; 1996 Jul; 62(2):283-91. PubMed ID: 8755829
[TBL] [Abstract][Full Text] [Related]
10. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.
Wettstein PJ; Colombo MP
J Immunol; 1987 Oct; 139(7):2166-71. PubMed ID: 2958540
[TBL] [Abstract][Full Text] [Related]
11. Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells.
Franksson L; Petersson M; Kiessling R; Kärre K
Eur J Immunol; 1993 Oct; 23(10):2606-13. PubMed ID: 8405061
[TBL] [Abstract][Full Text] [Related]
12. Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation.
Nevala WK; Paul C; Wettstein PJ
Transplantation; 1998 Feb; 65(4):559-69. PubMed ID: 9500633
[TBL] [Abstract][Full Text] [Related]
13. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
Korngold R; Leighton C; Mobraaten LE; Berger MA
Biol Blood Marrow Transplant; 1997 Jun; 3(2):57-64. PubMed ID: 9267665
[TBL] [Abstract][Full Text] [Related]
14. Antigen competition in cytotoxic T cell response to minor histocompatibility antigens.
Lai PK
Transplantation; 1985 Jun; 39(6):638-43. PubMed ID: 3873732
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen.
Mylin LM; Deckhut AM; Bonneau RH; Kierstead TD; Tevethia MJ; Simmons DT; Tevethi SS
Virology; 1995 Apr; 208(1):159-72. PubMed ID: 11831696
[TBL] [Abstract][Full Text] [Related]
16. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.
Sparer TE; Wynn SG; Clark DJ; Kaplan JM; Cardoza LM; Wadsworth SC; Smith AE; Gooding LR
J Virol; 1997 Mar; 71(3):2277-84. PubMed ID: 9032363
[TBL] [Abstract][Full Text] [Related]
17. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
18. B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.
Johnston JV; Malacko AR; Mizuno MT; McGowan P; Hellström I; Hellström KE; Marquardt H; Chen L
J Exp Med; 1996 Mar; 183(3):791-800. PubMed ID: 8642283
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1) encoded by the classical H7 minor histocompatibility locus.
Eden PA; Christianson GJ; Fontaine P; Wettstein PJ; Perreault C; Roopenian DC
J Immunol; 1999 Apr; 162(8):4502-10. PubMed ID: 10201988
[TBL] [Abstract][Full Text] [Related]
20. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
Berger M; Wettstein PJ; Korngold R
Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
